TP53 and neoplasm: Cross disease assessment of significantly prognostic subnetworks (Wald P < 0.05) revealed well-known oncogenic pathways such as Aurora Kinase A and B signaling, apoptosis, DNA repair, RAS signaling, telomerase regulation and P53 activity in all four tumor types (Supplementary Tables 6–9).